Both in Biotechnology
CRISPR Therapeutics AG vs Denali Therapeutics
Over the past year CRSP returned −8.2% and DNLI returned +40.5%; their daily moves had a correlation of 0.43.
CRSP −8.2% DNLI +40.5%Growth of $1, one year, split-adjusted
| Metric | CRSP | DNLI |
|---|---|---|
| Price | $51.78 | $20.96 |
| Market cap | $5.01B | $3.35B |
| Today | +3.57% | +7.76% |
| 1 month | −4.1% | +8.7% |
| 6 months | −6.0% | +2.7% |
| Year to date | −1.3% | +27.0% |
| 1 year | −16.5% | +36.5% |
| Revenue growth (YoY) | +1325.1% | — |
| Gross margin | 100.0% | 97.4% |
| Net margin | −879.6% | −3539.2% |
| P/E (TTM) | — | — |
| Price / sales | 198.9× | 929.6× |
| Net cash | $1.69B | $705.0M |
| Dividend yield | — | — |
| Volatility (60d) | 53.6% | 41.2% |
| Short % of float | 21.0% | 11.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).